HuR inhibitors belong to a class of chemical compounds that have garnered considerable attention within the realm of molecular biology and pharmacology due to their intricate mechanisms of action and implications in cellular processes. HuR, also known as human antigen R, is an RNA-binding protein that plays a vital role in post-transcriptional gene regulation. This protein is recognized for its ability to bind to specific adenine- and uridine-rich elements within the 3' untranslated regions (UTRs) of target messenger RNAs (mRNAs), consequently stabilizing these transcripts and enhancing their translation. HuR inhibitors are designed to disrupt these interactions, thereby offering a means of modulating gene expression on a post-transcriptional level.
Structurally diverse, HuR inhibitors can belong to various chemical classes, each with its distinct mechanisms of interference. They often exert their effects by binding to the RNA recognition motifs of HuR, preventing the protein's interaction with target mRNA sequences. By doing so, these compounds can influence mRNA turnover rates, translation efficiency, and impact cellular responses to various stimuli. Understanding the structural nuances of these inhibitors is essential, as it enables researchers to tailor compounds with greater specificity and potency, facilitating the exploration of their biological functions. In summary, HuR inhibitors constitute a class of compounds characterized by their ability to disrupt the interactions between the HuR protein and target mRNAs. While their precise mechanisms vary, their common goal is to modulate post-transcriptional gene regulation by hindering HuR's binding to specific RNA sequences.
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $412.00 | 32 | |
Dual tyrosine kinase inhibitor targeting EGFR and HER2 receptors. | ||||||
Neratinib | 698387-09-6 | sc-364549 sc-364549A sc-364549B sc-364549C sc-364549D | 5 mg 25 mg 100 mg 500 mg 1 g | $90.00 $210.00 $375.00 $740.00 $1225.00 | 4 | |
Irreversible inhibitor of EGFR, HER2, and HER4 kinases. | ||||||
Afatinib-d4 | 850140-72-6 (unlabeled) | sc-481821 | 10 mg | $4665.00 | ||
Irreversible inhibitor of EGFR, HER2, and HER4 kinases. | ||||||
Osimertinib | 1421373-65-0 | sc-507355 | 5 mg | $86.00 | ||
Selective inhibitor of mutant EGFR in non-small cell lung cancer. | ||||||
Canertinib | 267243-28-7 | sc-207397 | 10 mg | $260.00 | 3 | |
Irreversible inhibitor of EGFR, HER2, and HER4 tyrosine kinases. |